(c) 2024 PillSync.com

24 HR alprazolam 2 MG Extended Release Oral Tablet

1 INDICATIONS AND USAGE Alprazolam extended-release tablets are indicated for the treatment of panic disorder with or without agoraphobia, in adults. Alprazolam extended-release tablets are a benzodiazepine indicated for the treatment of panic disorder with or without agoraphobia, in adults. ( 1 )

Actavis Pharma, Inc.


5 months ago ROUND PINK R 87 24 HR alprazolam 2 MG Extended Release Oral Tablet

ROUND PINK R 87

5 months ago ROUND PINK R 87 24 HR alprazolam 2 MG Extended Release Oral Tablet

R 87 ROUND PINK

16 HOW SUPPLIED/STORAGE AND HANDLING

ALPRAZOLAM extended-release tablets, USP are available as follows: 0.5 mg : Each white to off-white, round tablet imprinted with on one side and 83 on the other contains 0.5 mg of

ALPRAZOLAM, USP. Tablets are supplied in bottles of 60 (NDC 0228-3083-06). 1 mg : Each yellow, round tablet imprinted with on one side and 84 on the other contains 1 mg of

ALPRAZOLAM, USP. Tablets are supplied in bottles of 60 (NDC 0228-3084-06). 2 mg : Each peach, round tablet imprinted with on one side and 87 on the other contains 2 mg of

ALPRAZOLAM, USP. Tablets are supplied in bottles of 60 (NDC 0228-3087-06). 3 mg : Each light green, round tablet imprinted with on one side and 86 on the other contains 3 mg of

ALPRAZOLAM, USP. Tablets are supplied in bottles of 60 (NDC 0228-3086-06). Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP. 1 1 1 1


More pills like ROUND R 87












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site